HomeMWG • FRA
add
InMed Pharmaceuticals Inc
Previous close
€2.86
Day range
€2.78 - €2.78
Year range
€2.66 - €5.68
Market cap
2.13M USD
Avg Volume
91.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 1.11M | -10.36% |
Operating expense | 2.67M | 31.45% |
Net income | -2.58M | -74.20% |
Net profit margin | -231.63 | -94.34% |
Earnings per share | — | — |
EBITDA | -2.15M | -30.52% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.46M | -63.88% |
Total assets | 8.50M | -44.27% |
Total liabilities | 2.32M | -6.57% |
Total equity | 6.18M | — |
Shares outstanding | 1.21M | — |
Price to book | 0.33 | — |
Return on assets | -58.16% | — |
Return on capital | -66.52% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -2.58M | -74.20% |
Cash from operations | -2.50M | -35.39% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 338.52K | -92.73% |
Net change in cash | -2.16M | -177.37% |
Free cash flow | -1.44M | -6.84% |
About
Founded
1981
Headquarters
Website
Employees
13
